The findings of the study revealed that compared with the traditional hCG trigger protocol, triggering with GnRH agonist followed by sequential use of hCG support could provide better luteal phase progesterone concentration, but four women still developed OHSS. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.